Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Lung Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Squamous Cell Carcinoma of Head and Neck 4Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Sezary Syndrome 2Recurrence 2Prostatic Neoplasms 2Neoplasms 2Mycosis Fungoides 2Lymphoma, Non-Hodgkin 2Hodgkin Disease 2Hematologic Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Thyroid Neoplasms 1Thrombocytosis 1Soft Tissue Neoplasms 1Sarcoma 1Respiratory Distress Syndrome 1Radiation Pneumonitis 1Primary Myelofibrosis 1

Interventions

Cisplatin 4Radiotherapy, Intensity-Modulated 3Radiotherapy 3pembrolizumab 2Cetuximab 2Biopsy 2utomilumab 1tremelimumab 1motexafin gadolinium 1durvalumab 1antineoplaston AS 2-1 1antineoplaston A10 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Radiosurgery 1Radiation 1Platinum 1Observation 1Nivolumab 1Ipilimumab 1Immunohistochemistry 1Immunoglobulin G 1Fluorouracil 1Fluorescent Antibody Technique 1Flow Cytometry 1Etoposide 1Electroacupuncture 1Drug Therapy 1Disulfides 1Diagnosis, Oral 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Oropharyngeal Neoplasms × Immunoglobulin G × Clear all
NCT03618134 2023-11-18

Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner

Jonsson Comprehensive Cancer Center

Phase 1/2 Terminated
19 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡